Business Segments

3 Months Ended

Apr. 02, 2022

Segment Reporting [Abstract]

Business Segments

11. Business Segments

The Company operates in one segment, ophthalmology. The Company develops, manufactures and markets medical devices. Our revenues arise from the sale of consoles, delivery devices, consumables, service, and support activities.

Revenue information shown by product group is as follows:

	Three Months Ended
(in thousands)	April 2, 2022		April 3, 2021
Cyclo G6	$	3,540	$	3,349
Retina		7,301		6,660
Other(1)		2,546		1,950
Total revenues	$	13,387	$	11,959
(1) Includes service contract revenues of $362 and $299 recognized during the three months ended April 2, 2022 and April 3, 2021, respectively. Includes $277 recognized revenue related to the exclusive distribution rights during the three ended April 2, 2022. Other also includes revenues from paid service, royalty, freight and legacy G probes.

Revenue information shown by geographic region, based on the sales destination, is as follows:

	Three Months Ended
(in thousands)	April 2, 2022		April 3, 2021
United States	$	6,819	$	5,564
Europe		3,273		2,417
Asia/Pacific Rim		2,735		3,174
Rest of Americas		560		804
Total revenues	$	13,387	$	11,959

Revenues are attributed to countries based on the location of end customers.

Other than the United States, Japan and the Netherlands accounted for at least 10% of the Company’s revenues during the three months ended April 2, 2022, representing 12% and 10%, respectively. Other than the United States, Japan accounted for more than 10% of the Company’s revenues during the three months ended April 3, 2021, representing 17%. The United States accounted for 50.9% and 46.5% of revenues for the three months ended April 2, 2022 and April 3, 2021, respectively.